Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Oct 30 - Nov 4
If nausea lasts more than 48 hours after early dosing, or if you experience vomiting that prevents you from keeping food or liquids down, seek medical advice
To qualify, a person must be enrolled in a Medicare Part D plan and meet one of three clinical criteriaassessed at the time you first started GLP-1 therapy, not at the time you apply: BMI of 35 or higher (no additional diagnosis required) BMI of 30 or higher, plus a diagnosis of heart failure with preserved ejection fraction, uncontrolled hypertension on two or more blood pressure medications, or chronic kidney disease stage 3a or higher BMI of 27 or higher, plus a diagnosis of pre-diabetes, previous heart attack, previous stroke, or symptomatic peripheral artery disease Your provider submits a prior authorization request attesting you meet the criteriayou dont need to opt in or take any action yourself
H.HeiatM.AlavianS
Dose increases are also implemented to overcome potential plateaus in weight loss
Why This Isn't a "Try This Dose" Article Unlike some research peptides where individuals may follow self-directed protocols, semaglutide is an FDA-regulated prescription medication (in the US) with equivalent regulatory status in the UK, EU, and Australia
